Search / Trial NCT00000180

AIT-082 Phase 1B Study

Launched by NATIONAL INSTITUTE ON AGING (NIA) · Oct 29, 1999

Trial Information

Current as of December 26, 2024

Completed

Keywords

Memory Mild Cognitive Impairment Nerve Growth Factors

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

Trial Officials

Michael Grundman, M.D., M.P.H.

Principal Investigator

University of California, San Diego

About National Institute On Aging (Nia)

The National Institute on Aging (NIA) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing our understanding of aging and age-related diseases. Through a robust portfolio of clinical trials, the NIA focuses on innovative research that aims to enhance the health and well-being of older adults. By fostering collaboration among scientists, healthcare professionals, and communities, the NIA seeks to translate research findings into practical solutions that improve the quality of life for aging populations. Their commitment to rigorous scientific inquiry and public health underscores their role as a leader in geriatric research and the pursuit of effective interventions for age-associated conditions.

Locations

Ann Arbor, Michigan, United States

St. Louis, Missouri, United States

San Diego, California, United States

Indianapolis, Indiana, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials